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GD3 detection in melanoma
Summary Gangliosides, cell surface glycosphingolipids, are 
implicated in diverse biologic functions potentially important for 
tumor growth. Because expression of the GD3 ganglioside may 
have an impact on the melanoma malignancy, and therefore on the 
patient prognosis, we evaluated the feasibility of a retrospective 
immunohistochemical study of GD3 in paraffin embedded biopsies 
of primary melanomas. Immunoperoxidase staining of frozen and 
deparaffinized sections of melanoma lesions with two anti-GD3 
antibodies was compared using Dako biotin-streptavidin detection 
kit. Residual ganglioside content was evaluated in the tissues 
submitted to routine histopathologic procedures using HPLC. A 
strong and reproducible staining was obtained with both antibodies 
on frozen sections of all 17 melanoma samples. However, only 
KM641 antibody could detect GD3 on deparaffinized sections. 
Biochemical quantification revealed that the Bouin fixative resulted 
in degradation of GD3. Additionally, most of GD3 was eluted from 
the tissue samples during dehydration and re-hydration steps. 
A subgroup of tumors particularly rich in GD3 could be detected 
on deparaffinized sections after standard formaldehyde fixation. 
Clinical evolution of such melanomas can now be compared to the 
group with low GD3 expression. However, any Bouin-fixed, paraffin-
embedded biopsies should be excluded from such a retrospective 
study.
Key wordS: melanoma, GD3 ganglioside, immunohistochemistry, 
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INTroduCTIoN
 Melanoma is a skin cancer showing an increas-
ing incidence. At present, early surgery is the only 
efficient treatment of this tumor. Determination of 
prognostic factors is crucial for classifying patients 
into homogeneous subgroups allowing develop-
ment of relevant clinical trials.
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 Gangliosides are ubiquitous glycosphingolipids 
expressed on the cell surface. They have been 
shown to be implicated in diverse biologic func-
tions such as attachment of cells to the extracel-
lular matrix (1), regulation of immune functions 
(2), regulation of cellular growth and proliferation 
(3), apoptosis (4), and angiogenesis (5). There-
fore, they may play a very important role in tumor 
growth. Normal melanocytes express gangliosides 
different from these of malignant melanocytes; in 
the former, GM3 ganglioside is mainly expressed, 
whereas GD3 ganglioside is more abundant in 
melanoma (6).
 Some authors have attempted to correlate the 
degree of malignancy of melanoma to the ganglio-
side composition but have reached contradictory 
conclusions, especially concerning the role of GD3 
(7-10). The correlation between the GD3 content 
in primary melanoma lesions and the clinical out-
come of patients has never been investigated.
 In previous studies, immunohistochemical de-
tection of in situ expressed GD3 was always per-
formed on frozen tissue sections (11-13). Such a 
technique is not compatible with the routine as-
sessment of primary melanomas because of a 
suboptimal morphological preservation of unfixed 
frozen biopsies.
 The aim of our study was to evaluate the fea-
sibility of immunohistochemical detection of GD3 
on paraffin-embedded biopsies. Indeed, the use of 
the routine histopathology block collections could 
allow for a retrospective study comparing initial in 
situ expression of GD3 by primary melanoma cells 
and clinical outcome in these patients.
maTerIaL aNd meTHodS
 Tissues 
 The study was approved by the local Ethics 
Committee of the Hospices Civils de Lyon. Upon 
obtaining an informed consent from the patients, 
frozen biopsies of surgically removed large malig-
nant melanomas were provided by Department of 
Dermatology, Hôtel-Dieu Hospital, Lyon, France. 
Sections of paraffin-embedded primary melanomas 
were also obtained from the same department.
 A frozen large metastasis of melanoma to a 
lymph node was used for ganglioside extractions 
after various steps of histological processing.
 monoclonal antibodies (mab)
 Two anti-GD3 monoclonal IgG3 antibodies were 
used. KM641 MAb (14) was provided by Dr Takao 
Taki (Otsuka Pharmaceutical, Co., Tokushima, Ja-
pan). C4F6 MAb (15) was produced by Dr. J. Por-
toukalian in our laboratory. Anti-CD1a (Monosan® 
clone 66IIC7, Sanbio, Uden, The Netherlands) 
and anti-PS100 (DakoCytomation, Carpinteria, 
USA) MAb were used as negative and positive 
controls of melanocyte detection, respectively.
 Immunohistochemistry (IHC)
 Four micrometer-thick frozen sections were 
stocked at -20 °C after 10-minute fixation in ice-
cold acetone (-20 °C). They were defrosted imme-
diately before IHC. For paraffin embedded tissues, 
IHC was preceded by microwave antigen retrieval: 
2x3 minutes at 750 Watts in a citrate buffer (Buffer 
for Antigen Retrieval, Dako ChemMate, Glostrup, 
Denmark).
 Sections were then rinsed in phosphate buff-
ered saline (PBS; pH 7.2) for 15 minutes. After 
5-minute incubation in 3% H2O2 (K0672 Peroxi-
dase block, DakoCytomation) and rinsing in PBS, 
non specific sites were blocked with an “antibody 
diluent with background reducing components” 
(DakoCytomation). A primary antibody was then 
added for 45 minutes at room temperature. Dilu-
tions were as follows: for KM641, 1/100 for frozen 
sections and 1/50 for deparaffinized sections; 
for C4F6, 1/200 for frozen sections and 1/50 for 
deparaffinized sections; for CD1a, 1/20; and for 
PS100, 1/400. After washing in PBS, the second-
ary mouse biotinylated antibody (K0672 Biotinyl-
ated Link, DakoCytomation) was added for 15 
minutes and rinsed with PBS. Sections were then 
incubated with streptavidin-peroxidase complex 
(K0672 HRP, DakoCytomation) for 15 minutes and 
washed in PBS. Amino-ethyl-carbazole substrate 
(K0672 AEC Substrate chromogen, DakoCytoma-
tion) was added for 15 minutes and after visual 
control of the developing coloration (red), followed 
by rinsing in water, the slides were counterstained 
with hematoxylin and mounted in Glycergel (Da-
koCytomation). 
 Semi-quantitative evaluation of Gd3 con-
tent in tumor fragments subjected to various 
histological procedures
 Sample preparation
 Roughly cubic 100 mg samples were taken 
from a large frozen lymph node metastasis of mel-
anoma. Some of them were fixed either in Bouin 
fixative (25 mL of 40% formaldehyde, 75 mL of 
picric acid in saturated water solution, 5 mL of 
glacial acetic acid) or in formol-eosin (4% water 
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solution of formaldehyde, pH 7, colored with eo-
sin; Carlo Erba, Paris, France) for different time 
periods. Some of the fixed samples were then 
manually dehydrated, using the same protocol as 
in our routine dermatopathology laboratory: 1 hour 
in 70° ethanol, 1 hour in pure ethanol, 5x1 h 30’ in 
pure ethanol, 1 hour and 1 h 30’ in methylcyclo-
hexan. Each dehydrated sample was then cut into 
inframillimetric slices, which were immersed in 
Roti®-Histol, a xylene substitute used for deparaf-
finization (Carl Roth, Lauterbourg, France) (2x10 
minutes). At last, the samples were rehydrated in 
graded ethanol baths following the routine derma-
topathology laboratory protocol.
 Thereafter, semi-quantitative evaluation of the 
ganglioside content was performed in the samples 
that had been fixed only, and in the samples that 
had been fixed, dehydrated and rehydrated. Each 
series also included a thawed sample that had not 
been chemically treated. The processed samples 
were compared to that control.
 Ganglioside analysis was performed on 
all tissue samples and on the solvents used 
for dehydration and re-hydration (ethanol and 
methylcyclohexane), except for the Roti®-Histol 
baths that could not be evaporated.
 Lipid extraction
 Total lipids were extracted from each specimen 
with a chloroform-methanol (C/M) mixture (1:1). 
The extract was then filtered and evaporated. The 
dry lipid extract was dissolved with 6 mL of C/M. 
Upon the addition of 2 mL of PBS (16) and thor-
ough shaking, centrifugation of the mixture led to 
separation into two phases. The upper, aqueous 
phase contained gangliosides.
 Purification of gangliosides
 The gangliosides were recovered from the 
aqueous phase according to Popa et al. (17). The 
aqueous phase was applied to a copolymer col-
umn (Envi-Chrom P, Supelco-Park, Bellefonte, 
USA) that had previously been conditioned with 
a methanol/PBS mixture (1:1). The column was 
then rinsed with distilled water and gangliosides 
were eluted with 4 mL of methanol and 4 mL of 
C/M (1:1). The ganglioside fraction was dried and 
dissolved in 100 µL of C/M (2:1). Ten µL (for un-
fixed and fixed tissue samples) or 20 µL (for fixed, 
dehydrated and rehydrated samples) of extracts 
were applied to a HPLC plate (Silica Gel 60F254 
10x10 cm; Merck, Darmstadt, Germany). The plate 
was then placed in a glass tank and samples were 
migrated in chloroform/methanol/water (55:45:10, 
v/v/v) solvent system containing 0.22% (w/v) of 
aqueous CaCl2. Visualization was performed with 
a resorcinol-HCl spray reagent (18) followed by 
heating at 120 °C.
 Normal phase HPLC purification of neutral 
glycolipids
 The neutral glycolipids were isolated according 
to Bodennec et al. (19). The lower organic solvent 
phase was dried, dissolved in 500 µL of chloro-
form and applied to an aminopropyl-bonded silica 
gel column Supelclean LC-NH2 (Supelco, L’Isle 
d’Abeau, France) that had previously been condi-
tioned with hexane. The column was first eluted 
with diethylether, then with a C/M mixture (23:1) 
and finally with a diisopropylether/acetic acid mix-
ture (98:4) to remove the first three lipid fractions. 
Monohexosyl ceramides and dihexosyl ceramides 
were then eluted with an acetone/methanol mix-
ture (9:1.2). This fraction was then dried and dis-
solved in 100 µl of C/M (2:1). Ten µL of the neutral 
glycolipid extract were then applied to a HPLC 
plate (Silica Gel 60F254; Merck) and run in chlo-
roform/methanol/water (65:20:3, v/v/v). Visualiza-
tion was performed with an orcinol-H2SO4 spray 
reagent and heating at 150 °C.
 Semi-quantitative evaluation and statistical 
analysis
 The plates were scanned with a photodensi-
tometric scanner (ChromatoScan CSD-930, Shi-
madzu, Kyoto, Japan). Peak areas of the ganglio-
sides of interest were compared between the test 
and control samples and the ratio was calculated. 
The ratios obtained for Bouin fixed tissues and 
formol-eosin fixed tissues were compared using 
Student’s t-test.
reSuLTS
 Reactivity with KM641 antibody to GD3 could 
be observed on deparaffinized sections of mela-
nomas, although it was less uniform than on the 
frozen tissue sections (Fig. 1). All frozen sections 
of melanomas included in the study were reac-
tive with both antibodies directed to GD3. IHC 
performed on 17 biopsy samples from 13 patients 
(large primary melanomas and subcutaneous me-
tastases) showed, in all cases, a diffuse cytoplas-
mic staining of malignant melanocytes with C4F6 
and KM641 antibodies (Fig. 1A). Only sparse 
staining of individual cells was observed with 
the control anti-CD1a antibody (Fig. 1B). It was 
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difficult to estimate relative variations in the inten-
sity of GD3 staining within a given tumor because 
of the presence of GD3 reactivity not only in the 
melanoma cells but often also in the neighboring 
epithelial or connective tissues.
 Specific staining of GD3 was less frequently 
observed in the deparaffinized tissues. Ten of the 
paraffin embedded tissues were fixed with for-
mol-eosin. The staining with KM641 antibody was 
absent in 6 (Fig. 1C), weak in 2 , and strong in 
2 cases (Fig. 1E). Biopsies of melanoma fixed in 
Bouin were only occasionally reactive with KM641 
antibody (not shown). No staining was observed 
with C4F6 MAb, whatever the fixative used. 
 Most of the GD3 was either hydrolyzed or elut-
ed during routine histopathologic preparation. The 
quantity of samples used in this study was limited 
because ganglioside extractions require large 
amounts of tissue. The pooled results of three 
separate GD3 extractions from 3 distinct samples 
of melanoma tumors are shown in Figure 2. There 
were only slight variations in the measured GD3 
content when extractions were repeated in the 
same conditions. When the tumor samples were 
fixed in formol-eosin, there was only a slight de-
crease in the GD3 content, whereas Bouin fixa-
tion induced a significant decrease. After 88 hours 
of fixation, the difference in GD3 content between 
Bouin fixed (3 samples; mean residual quantity 
= 32% of the initial value) and formol-eosin fixed 
samples (3 samples; mean residual quantity = 
93% of the initial value) was statistically significant 
(p<0.05).
 When the samples were fixed for 12 hours or 
88 hours in Bouin, the GM3/GD3 ratio and the lac-
tosyl-ceramide content increased with the dura-
tion of fixation, indicating conversion of GD3 into 
its precursor forms. Such a phenomenon was not 
observed when the samples were fixed in formol-
eosin (not shown). 
 The results of biochemical analysis of the fixed 
and solvent-treated samples are summarized 
in Figure 3. When the fixative was Bouin, prac-
tically no GD3 remained in the tissue. When the 
fixative was formol-eosin, the residual GD3 con-
tent was 25.5±5.5% after 12 hours of fixation and 
Figure 1. Melanoma sections reacted with the KM641 antibody in a manner depending on the tissue fixa-
tion procedures. Frozen sections of malignant melanoma lesions were strongly and specifically stained 
with KM641 MAb, whereas deparaffinized sections showed increased heterogeneity. (A) Frozen section 
of a melanoma metastasis reactive with KM641 MAb (1/100), X200; (B) the same metastasis (a consecu-
tive frozen section) showing only sparse cell staining with control CD1a MAb (1/20), X200; (C) and (E): 
two different formol-eosin fixed primary melanomas showing variable degrees of staining with KM641 
MAb (1/50; deparaffinized sections); (D) the KM641-negative tumor was readily stained with anti-PS100 
antibody (1/400; positive control on a section consecutive to C; X100); and (F) negative control with CD1a 
MAb (1/20; a section consecutive to E; X200).
Bars = 100 µm; The bar in C is also valid for D; and that in E is also valid for A, B, F.
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13.5±1.5% after 88 hours of fixation ( 2 samples; 
mean ± standard deviation), when compared to the 
unfixed, untreated samples. The number of pro-
cessed samples was too low to draw a conclusion 
concerning statistical significance of the difference 
observed. GD3 was found in the solvents used for 
dehydration and re-hydration of the tumor tissue. 
More GD3 was found in the pooled solvent baths 
when the fixative was formol-eosin compared to 
Bouin (not shown). We concluded that most of the 
GD3 was extracted from the tumor samples during 
the phases of dehydration and re-hydration.
 dISCuSSIoN
 Gangliosides are part of the lipids constituting 
cell membrane “rafts”, i.e. important platforms of 
cell signaling involved in the regulation of cell be-
havior. In melanoma, as in other situations, the 
composition of the rafts may apparently influence 
cell function, and thus constitutes important infor-
mation from the practical point of view (20). Also, 
gangliosides released from the surface of mela-
noma cells are able to modulate the function or 
even induce apoptosis of other cell types, e.g., im-
munocompetent dendritic cells (21). The authors 
of previously published studies have often drawn 
conflicting conclusions regarding the correlation 
between GD3 expression and the degree of mela-
noma malignancy. Results of a previous study con-
ducted in our laboratory (9) have suggested that 
primary tumors with a low expression of GD3 are 
more prone to give metastasis than tumors with 
a high GD3 expression. Also, analysis of ganglio-
sides expressed on melanoma cells issued from 
primary tumors and their metastases indicated 
that GD1a may be a better marker of metastatic 
phenotype than GD3 (22). On the other hand, two 
other groups (7,8) have found more GD3 in most 
aggressive tumors. In neuroblastoma, Zeng et al. 
demonstrated a decrease in GD3 content to be as-
sociated with a reduction of angiogenesis, which 
resulted in slower tumor growth (23). Accordingly, 
other authors have linked malignant properties of 
melanoma to GD3-dependent signaling through 
the integrin receptor junctions (24).
 The relationship between the GD3 content in 
primary melanomas and the clinical outcome of 
the disease in humans has never been investi-
gated and remains an important unsolved issue.
 Previous studies aiming at detecting GD3 in 
melanocytes by IHC were always performed on 
frozen sections. Dippold et al. compared the stain-
Figure 2. GD3 extraction from malignant mela-
noma tumors yielded various quantitative results 
after the initial tissue fixation step. Three distinct 
samples were extracted before and after 88-hour 
fixation with formol-eosin or Bouin; the amounts of 
glycolipids quantified with thin layer chromatogra-
phy were expressed as a ratio of GD3 in the fixed 
over the unfixed sample (mean residual fraction ± 
SD). Fixation in Bouin induced a significant loss of 
GD3 (p<0.05).
Figure 3. Further loss of GD3 from the samples 
was observed after the treatment with organic sol-
vents during dehydration and re-hydration steps. 
Residual GD3 in the samples was expressed as 
a ratio between the values obtained before and 
after histologic processing (mean residual frac-
tion ± SD). Bouin fixation for 88 hours followed 
by solvent baths resulted in complete depletion of 
gangliosides from the tissues. The impact of sol-
vents on formol-eosin fixed tissues was less pro-
nounced, although only 25.5% of the initial GD3 
values were still present in the samples fixed for 
12 hours.
Debarbieux et al.      Acta Dermatovenerol Croat
GD3 detection in melanoma      2009;17(3):209-218
214
ing with R24 anti-GD3 antibody on frozen sections 
of 21 primary melanomas and 37 metastases (11). 
They found strong staining of more than 60% of 
malignant melanocytes in all of the primary tu-
mors; in most cases, the staining exceeded 80% 
of cells. GD3 expression in metastases was also 
strong but more heterogeneous. Hersey et al. also 
found strong staining of malignant cells with the 
same antibody (12). In both studies, there was a 
tendency towards a lower expression of GD3 in 
metastasis, although it was not statistically signifi-
cant.
 Our results of GD3 detection on frozen sec-
tions of melanoma samples obtained with different 
primary antibodies are in agreement with previous 
reports (11-13).
 The staining intensity obtained on frozen sec-
tions was difficult to interpret because of the re-
activity of adjacent tissues. The presence of GD3 
labeling on cells and stromal fragments surround-
ing tumor masses could be due to diffusion and 
passive transfer of the ganglioside molecules from 
melanoma. However, staining of other normal and 
tumoral tissues, and specifically of the normal hu-
man skin, has previously been reported (25) and 
could result from in situ ganglioside production un-
der the influence of local or distant tumor-derived 
stimuli.
 In conclusion, evaluation of the level of GD3 
expression with IHC on frozen sections appears to 
be difficult because nearly all tumors are intensely 
stained and labeling of the infiltrated and adjacent 
tissues represents a confusion factor. Additionally, 
only routine chemical fixation guarantees the reli-
able histopathologic diagnosis of primary melano-
mas, so frozen sections of small primary lesions 
are not available for ethical reasons.
 The principal goal of our study was, therefore, 
to assess the feasibility of GD3 IHC on deparaf-
finized sections, in order to perform a retrospec-
tive study on archived blocks of melanoma sam-
ples. Indeed, we found that such staining could 
be observed on some deparaffinized sections 
but the frequency and intensity of GD3 detection 
was clearly much lower than on frozen samples 
from the same tumors. We could further verify that 
staining corresponded to a detectable content of 
GD3 in the study tissues and could check the im-
pact of the histologic preparation process on this 
content.
 Schwarz and Futerman demonstrated that 
fixation of cultured neurons in formaldehyde de-
creased their GD3 detection by 10% (26). Suzuki 
found the ganglioside content to have dramatically 
decreased in brains that had been fixed for sev-
eral years in formaldehyde (27). Significant varia-
tions observed from the sixth week of fixation on 
could have been induced by increasing acidifica-
tion of formaldehyde resulting in hydrolysis of si-
alic acids. However, no significant variations were 
observed when fixation lasted for up to 10 days. 
Our data showed the fixation step in Bouin fixative 
to induce a significant decrease in GD3 content 
compared to the frozen tissue or formaldehyde-
fixed tissue. Concomitantly, there was a relative 
increase in GM3 and lactosyl-ceramide, which are 
precursors of GD3. According to the data reported 
by Suzuki (27), it is likely that the acidity of Bouin 
fixative, that contains picric acid, causes hydroly-
sis of both sialic acids on GD3, thus converting 
these gangliosides into precursor forms. Tissues 
fixed that way are therefore not fit for studies on 
GD3 expression. On the other hand, formol-eosin 
with its neutral pH did not cause any significant 
variation of GD3 during a few days of fixation and 
proved compatible with such studies. 
 During the second step of the procedure, or-
ganic solvents partly extracted GD3 from the tis-
sue sample, as shown by the results of biochemi-
cal analysis of the ethanol and methyl cyclohexane 
baths. It is logical that fewer GD3 was extracted 
when the fixative was Bouin since residual GD3 
content was already lower in that sample after the 
fixation step.
 Following the complete procedure, practically 
no residual GD3 remained in the Bouin-fixed sam-
ple; only a very small amount was detected when 
the fixation was very short (less than 12 hours). It 
may explain that some of our Bouin fixed tumors 
could still be stained with the KM641 antibody. 
We conclude that detection of GD3 ganglioside 
on deparaffinized sections of routinely Bouin-fixed 
melanoma is not reliable and retrospective studies 
on such tissues should not be undertaken.
 When the fixative was formol-eosin, much GD3 
was extracted during the dehydration, deparaf-
finization and re-hydration steps. Nevertheless, 
there still remained a detectable residual GD3 in 
the sample, amounting to approximately 13%-25% 
of the initial content, depending on the duration of 
fixation. We cannot exclude further variations due 
to the formol fixation should this step exceed 88 
hours evaluated in this study; however, such vari-
ations appear to be limited compared to the in vivo 
variability of ganglioside expression. Ravindranath 
et al. (7) observed variations of GD3 comprised 
between 3.24 and 173 µg/g of dry tissue in their 
Debarbieux et al.      Acta Dermatovenerol Croat
GD3 detection in melanoma      2009;17(3):209-218
ACTA DERMATOVENEROLOGICA CROATICA
215
series of lymph node metastases (28 samples; 
mean ± SD = 49.2±40 µg/g). In another series of 
cutaneous metastatic melanomas (8), the extreme 
values were 7 and 907 µg/g of dry tissue (19 sam-
ples; mean ± SD = 261±260 µg/g). Therefore, it 
is likely that the intensity of anti-GD3 staining of 
our formol-eosin fixed samples corresponded to 
the real residual content in GD3 depending on the 
initial values expressed in the studied tumors.
 Thus, the tumors that strongly express GD3 
may be identified by this technique. A retrospective 
study on formaldehyde fixed tumors can therefore 
be proposed in order to evaluate the clinical out-
come of patients with primary melanomas differ-
ing in GD3 expression. This should help define the 
prognostic value of the GD3 marker in the newly 
occurring melanomas.
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